The long-term objectives of this research plan are to investigate at the cellular, biochemical and molecular levels three specific areas of importance related to hormones that affect mineral ion metabolism. Studies will focus on: 1. mechanisms of action of bone resorption-stimulating factors (PTH, PGE2 and specific growth factors). Experiments will emphasize actions on Ca2+ metabolism in isolated bone cells, and regulation of protein phosphorylation, protein kinase activity, phospholipid and arachidonic acid turnover. 2. Vitamin D action in a new model system. The molecular mechanisms by which 1,25(OH)2D3 and Ca2+ act interdependently to regulate expression of the prolactin gene and prolactin synthesis will be examined in clonal strains of rat pituitary cells in culture. 3. Calcitonin. Studies on the early actions of calcitonin on isolated bone cells in culture will parallel and contrast with those of bone resorption-stimulating factors on cellular Ca2+ metabolism, protein phosphorylation and phospholipid turnover. In addition, the mechanism by which Ca2+ directly enhances calcitonin secretion by clonal strains of C-cells will be investigated. In the human medullary thyroid carcinoma syndrome, new diagnostic and prognostic studies will involve radioimmunoassay, immunocytochemistry, somatic and tumor cell culture, and chromosomal analysis. The experiments proposed are designed to investigate several fundamental aspects of hormones affecting mineral metabolism and to relate these findings to clinically important disorders of bone metabolism in the human including osteoporosis, hyperparathyroidism and the hypercalcemias of cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK010206-22
Application #
3224675
Study Section
General Medicine B Study Section (GMB)
Project Start
1974-09-01
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
22
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Belinsky, G S; Tashjian Jr, A H (2000) Direct measurement of hormone-induced acidification in intact bone. J Bone Miner Res 15:550-6
Frolik, C A; Cain, R L; Sato, M et al. (1999) Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. J Bone Miner Res 14:163-72
Fukayama, S; Royo, M; Sugita, M et al. (1998) New insights into interactions between the human PTH/PTHrP receptor and agonist/antagonist binding. Am J Physiol 274:E297-303
Weilbaecher, K N; Hershey, C L; Takemoto, C M et al. (1998) Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med 187:775-85
Barrett, M G; Belinsky, G S; Tashjian Jr, A H (1997) A new action of parathyroid hormone. receptor-mediated stimulation of extracellular acidification in human osteoblast-like SaOS-2 cells. J Biol Chem 272:26346-53
Goad, D L; Rubin, J; Wang, H et al. (1996) Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137:2262-8
Monroe, J J; Tashjian Jr, A H (1996) Palytoxin modulates cytosolic pH in human osteoblast-like Saos-2 cells via an interaction with Na(+)-K(+)-ATPase. Am J Physiol 270:C1277-83
Monroe, J J; Tashjian Jr, A H (1996) Pretreatment with 17 beta-estradiol attenuates basal- and PTH-stimulated membrane adenylyl cyclase activity in human osteoblast-like SAOS-2 cells. Biochem Biophys Res Commun 225:320-5
Monroe, J J; Tashjian Jr, A H (1995) Actions of palytoxin on Na+ and Ca2+ homeostasis in human osteoblast-like Saos-2 cells. Am J Physiol 269:C582-9
Fukayama, S; Tashjian Jr, A H (1994) Involvement of alkaline phosphatase in the modulation of receptor signaling in osteoblasts: evidence for a difference between human parathyroid hormone-related protein and human parathyroid hormone. J Cell Physiol 158:391-7

Showing the most recent 10 out of 33 publications